Johnson Brady 4/A
4/A · Cidara Therapeutics, Inc. · Filed Oct 5, 2021
Insider Transaction Report
Form 4/AAmended
Johnson Brady
Dir. of Finance & Controller
Transactions
- Award
Common Stock
2021-09-30+20,750→ 47,119 total
Footnotes (2)
- [F1]All RSUs vest in three equal annual installments, with 1/3 vesting on each of September 10, 2022, 2023, and 2024, subject to continuous service through each such vesting date.
- [F2]This amendment is being filed to correct the end of period holdings which were overstated by 80 shares.